We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Grants Cellceutix’s Kevetrin Orphan Drug Designation for Retinoblastoma AGTC Snags Orphan Drug Designation for Achromatopsia Gene Therapy EC Grants Marketing Authorization to Gilead’s HIV-1 Drug EC Grants Two Approvals to Novartis’ Cosentyx Long-Term Survival Benefit Seen in Celldex’s Rintega